Wiesbaden, Germany

Wilfried Greve


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Wiesbaden, DE (1981)
  • Rodermark, DE (1989)

Company Filing History:


Years Active: 1981-1989

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wilfried Greve: Innovator in Medicinal Chemistry

Introduction

Wilfried Greve is a notable inventor based in Wiesbaden, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyridine compounds. With a total of 2 patents to his name, Greve's inventions have the potential to impact various medical applications.

Latest Patents

Greve's latest patents include multiply substituted pyridine 1-oxide compounds, which are particularly useful in the development of 4-Aminopyridines. These compounds are essential in creating medicaments that contain 4-Aminopyridines of specific formulas, where R¹ can be hydrogen or an alkyl group of up to six carbon atoms. His work in this area showcases his expertise and dedication to advancing medicinal chemistry.

Career Highlights

Throughout his career, Wilfried Greve has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His role at Hoechst has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in medicinal compounds.

Collaborations

Greve has worked alongside esteemed colleagues such as Ulrich Elben and Karl Rudolph. These collaborations have further enriched his research and development efforts, leading to innovative solutions in the field of chemistry.

Conclusion

Wilfried Greve's contributions to medicinal chemistry through his patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments and compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…